Efficacy of azithromycin 1% and 1.5% ophthalmic solutions compared to tobramycin 0.3% eye drops: A systematic review and meta-analysis

被引:2
|
作者
Alemu, Birhanu Motbaynor [1 ]
Worku, Teshager [2 ]
机构
[1] Haramaya Univ, Coll Hlth & Med Sci, Sch Pharm, POB 235, Harar, Ethiopia
[2] Haramaya Univ, Coll Hlth & Med Sci, Sch Nursing & Midwifery, Harar, Ethiopia
来源
SAGE OPEN MEDICINE | 2020年 / 8卷
关键词
Azithromycin; eye diseases; eye drops; tobramycin; efficacy; PURULENT BACTERIAL CONJUNCTIVITIS; CLINICAL-EFFICACY; 3-DAY TREATMENT; EYEDROPS; SAFETY; SIGNS; MULTICENTER; SYMPTOMS; TRIAL;
D O I
10.1177/2050312120958846
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Azithromycin 1% and 1.5% ophthalmic preparations are used widely in clinical practice for the treatment of signs and symptoms of eye diseases. The aim of this study was to render conclusive evidence by comparing the efficacy of azithromycin 1% and 1.5% over tobramycin 0.3% ophthalmic solutions for the treatment of eye diseases in a short duration in terms of bacterial resolution, the cure rate, and resolving clinical sign and symptoms. Methods: Systematic searches were performed in the electronic database (MEDLINE, Embase, Emcare, CINAHL, Scopus, PubMed, ProQuest, and Web of Science) and other sources. Multicenter randomized controlled trial studies conducted in English were identified and screened. Analysis of individual studies was conducted using the OpenMeta-analyst and Review Manager Version 5.3 software. Results: Eleven studies were included in the systematic review and meta-analysis. In clinical cure rate, azithromycin 1% and 1.5% eye drops were more effective than tobramycin 0.3% eye drops in short duration dosing (<= 5 days) with a twice-a-day regimen (relative risk = 1.13; 95% confidence interval: 1.008, 1.28), whereas on increased duration (>5 days), azithromycin is almost similarly as effective as tobramycin (relative risk = 1.007; 95% confidence interval: 0.96, 1.05). There was no significant difference in efficacy of bacterial resolution of azithromycin (1%, 1.5%) eye drops compared to tobramycin (0.3%) eye drops (relative risk = 0.99; 95% confidence interval: 0.96, 1.018). Azithromycin eye drops are effective in improving the signs and symptoms of eye disease. Conclusion: Azithromycin 1% or 1.5% is more effective in the clinical cure rate of eye disease than tobramycin 0.3% eye drops in <= 5 days of treatment. It is also the best choice of treatment for improving the signs and symptoms of eye disease. So that we recommend clinicians to use azithromycin 1% or 1.5% eye drops.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Efficacy of Houttuynia eye drops for the treatment of vernal keratoconjunctivitis A systemic review and meta-analysis protocol
    Yu, Lingyan
    Chen, Xueying
    Yu, Zhenwei
    MEDICINE, 2019, 98 (26)
  • [22] Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery A protocol for systematic review and meta-analysis
    Wang, Chunyue
    Cao, Yana
    Chen, Xi
    Cai, Mingming
    Huang, Wei
    MEDICINE, 2020, 99 (49) : E23131
  • [23] Efficacy and Safety of Azelnidipine as an Antihypertensive Compared to Amlodipine: A Systematic Review and Meta-analysis
    Debkumar Pal
    Shampa Maji
    Rituparna Maiti
    High Blood Pressure & Cardiovascular Prevention, 2023, 30 : 401 - 410
  • [24] Efficacy and Safety of Azelnidipine as an Antihypertensive Compared to Amlodipine: A Systematic Review and Meta-analysis
    Pal, Debkumar
    Maji, Shampa
    Maiti, Rituparna
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2023, 30 (05) : 401 - 410
  • [25] A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome
    Yang, Yun-Jung
    Lee, Won-Young
    Kim, Young-jin
    Hong, Yeon-pyo
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (05) : 1 - 14
  • [26] The efficacy of buprenorphine compared with dexmedetomidine in spinal anesthesia: a systematic review and meta-analysis
    Cansian, Joao Marcos
    Giampaoli, Angelo Zanin D'Angelo
    Immich, Liege Caroline
    Schmidt, Andre Prato
    Dias, Andrei Sanson
    BRAZILIAN JOURNAL OF ANESTHESIOLOGY, 2024, 74 (06):
  • [27] Autologous Serum Eye Drops versus Artificial Tear Drops for Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Wang, Leying
    Cao, Kai
    Wei, Zhenyu
    Baudouin, Christophe
    Labbe, Antoine
    Liang, Qingfeng
    OPHTHALMIC RESEARCH, 2020, 63 (05) : 443 - 451
  • [28] Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis
    Buendia, Jefferson Antonio
    Patino, Diana Guerrero
    Salazar, Andres Felipe Zuluaga
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [29] Autologous serum eye drops for patients with dry eye disease: a systematic review and meta-analysis of randomized controlled trials
    He, Chang-Zhu
    Zeng, Zhao-Jun
    Liu, Jun Qiao
    Qiu, Qin
    He, Yu
    FRONTIERS IN MEDICINE, 2024, 11
  • [30] Efficacy and Safety of Ophthalmic Preparations of Glucocorticoids in Patients with Epidemic Keratoconjunctivitis: A Systematic Review and Meta-analysis
    Liu, Pengpeng
    Li, Guangyao
    Han, Mei
    Cheng, Xiao
    Cui, Ying
    Yang, Qinglin
    Zhang, Chao
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (03) : 476 - 483